di Reumatologia, S.I. (tran.) (2026) “PO:20:007 | Mind the rebound: ctx dynamics after denosumab discontinuation and zoledronate rescue in patients with postmenopausal osteoporosis or with cancer treatment-induced bone loss: Federico Aldegheri1, Francesca Ruzzon1, Matteo Appoloni1, Giovanni Adami1, Davide Gatti1, Maurizio Rossini1, Angelo Fassio1, Ombretta Viapiana1 | 1Università di Verona, Italy”, Reumatismo, 77(s1). doi:10.4081/reumatismo.2025.2342.